New Deal
Todd Barker
CEO at SURVEYOR CAPITAL
Investor
Deal Bio
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.
Elevatebio
The Invus Group
£137m
24 dealmakers
Chinook Therapeutics
Ecor1 Capital
£80m
15 dealmakers
Kronos Bio
Perceptive Advisors
£118m
18 dealmakers
ANNEXON
Adage Capital Management
£81m
16 dealmakers
Velosbio
Cormorant Asset Management
£105m
VECTIVBIO
£84m
35 dealmakers
Miragen Therapeutics
VENROCK
£70m
19 dealmakers
Ikena Oncology
Omega Funds
£88m
Artiva Biotherapeutics
Acuta Capital
value n/a
Matrix Capital Management
£376m
25 dealmakers
Boundless Bio
Wellington Management
£75m
Gh Research
Deerfield Management Company
£91m
20 dealmakers
Nikang Therapeutics
Surveyor Capital
£141m
29 dealmakers
SHOUTI
Casdin Capital
£72m